HIV Cure Research
Therapeutic development and validation studies
Early Access – Select Customers
High-Resolution Sequencing of the HIV Latent Reservoir
Breakthrough technology enabling ultra-sensitive detection of latent HIV in tissue
Request Early AccessThe Challenge
Detecting latent HIV reservoirs has been one of the most significant bottlenecks in HIV cure research. Traditional methods lack the sensitivity to measure extremely low levels of latent HIV hiding in tissue reservoirs, making it nearly impossible for pharmaceutical companies to accurately assess the efficacy of potential cure strategies.
Our Unique Solution
Vivid Bio Labs has developed the only commercially available solution capable of measuring ultra-low levels of latent HIV in tissue with unprecedented sensitivity and precision.
- Quantify proviral DNA down to one per million cells
- Single-cell resolution and specificity
- Full length viral DNA sequences
- Distinguishes between intact and defective proviruses
- Proven results with select early access customers
Key Applications
Reservoir Quantification
Latent reservoir measurement and monitoring
Treatment Efficacy
Monitoring and assessment of cure strategies
Clinical Trial Support
Endpoint validation and biomarker development
Pharmaceutical Partnerships
Collaborative research and development programs
How It Works
1
Sample Collection & Preparation
Custom protocols for tissue samples with specialized handling requirements
2
Proprietary Processing
Advanced sample preparation techniques optimized for ultra-sensitive detection
3
Targeted Deep Proviral Sequencing
Ultra-sensitive detection method with long read sequencing to capture full-length viral DNA sequences
4
Data Analysis & Validation
Comprehensive bioinformatics pipeline with rigorous quality control
5
Results Delivery
Detailed reports and raw data access with expert interpretation
Why Partner With Us
Breakthrough Technology
Proprietary breakthrough technology unavailable elsewhere in the market
Deep Expertise
Established expertise in HIV reservoir biology and cure research
Pharmaceutical Partnerships
Established partnerships with leading pharmaceutical companies
Early Access Program
Dedicated support and priority access for select customers
Proven Track Record
Demonstrated success in advancing HIV cure research initiatives
Technical Specifications
Sample Requirements
Tissue samples with specialized preparation guidelines and handling protocols
Turnaround Time
Typical delivery: 2-3 weeks from sample receipt
Deliverables
Quantitative viral load data, tissue mapping, and comprehensive analysis reports
Quality Control
Rigorous validation metrics and comprehensive quality assurance protocols
Ready to Advance HIV Cure Research?
Join our early access program and be among the first to leverage this breakthrough technology for your HIV cure research initiatives.
Dedicated pharmaceutical partnership support available for qualified organizations.